Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02009449 |
Title | A Phase 1 Study of AM0010 in Patients With Advanced Solid Tumors |
Acronym | IVY |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | ARMO BioSciences |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
UCLA Medical Hematology & Oncology | Los Angeles | California | 90024 | United States | Details | |
UCSF | San Francisco | California | United States | Details | ||
Sarah Cannon Research Institute at HealthONE | Denver | Colorado | 80218 | United States | Details | |
Florida Cancer Specialists & Research Institute | Sarasota | Florida | 34232 | United States | Details | |
Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Stephenson Cancer Center at Oklahoma University TSET Phase 1 Program | Oklahoma City | Oklahoma | 73104 | United States | Details | |
Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
The University of Texas M.D. Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
South Texas Accelerated Research Therapeutics | San Antonio | Texas | 78229 | United States | Details |